Editorials

Being a modern pharmaceutical company

BMJ 1998; 317 doi: http://dx.doi.org/10.1136/bmj.317.7167.1172 (Published 31 October 1998) Cite this as: BMJ 1998;317:1172

Involves making information available on clinical trial programmes

  1. Richard Sykes, Chairman
  1. Glaxo Wellcome, Greenford, Middlesex UB6 0NN

    What does it mean to be a modern pharmaceutical company? Rapid changes in society and advances in science and medicine mean that the pharmaceutical industry has several important roles today that would not have been apparent as recently as 10-15 years ago. To provide medicines of value the modern pharmaceutical company has to meet the needs of patients for better medicines while taking full account of the realities of healthcare economics. It has to harness scientific advances, particularly in genetics and information technology, and work in partnership with researchers, healthcare providers, and governments. One substantial outcome of these partnerships is a better understanding of the need for openness and transparency in clinical trials.

    For healthcare providers the cost of health care is a paramount issue, and the industry knows that new medicines have to deliver real benefits over existing ones. Delivering better medicines—demonstrated …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe